You are here

Article Text

Article menu
Download PDFPDF
Mental health
Early intervention in autism: where do we go from here?

https://doi.org/10.1136/ebnurs-2024-103953

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests EA has received research funding from Supernus Pharmaceuticals, Roche/Genentech Phanaceuticals, Otsuka Pharmaceuticals, Axial, Yamo, Maplight. Myndlift, YoungLiving Essential Oils and National Institute of Health (USA, R01 MH 100144), has consulted with Pfizer Parmaceuticals, Yamo and CHADD and been on advisory boards for Otsuka and Roche/Genentech.

    • Provenance and peer review Commissioned; internally peer reviewed.